Analysis and Commentary STEVEN GROSSMAN 4/3/21 Analysis and Commentary STEVEN GROSSMAN 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More Analysis and Commentary STEVEN GROSSMAN 1/10/20 Analysis and Commentary STEVEN GROSSMAN 1/10/20 FDA Is Its People Read More STEVEN GROSSMAN 11/21/19 STEVEN GROSSMAN 11/21/19 Senate HELP Committee Interviews Stephen Hahn, MD Read More STEVEN GROSSMAN 1/7/19 STEVEN GROSSMAN 1/7/19 Alliance Releases FDA Shutdown Toolkit Read More Analysis and Commentary STEVEN GROSSMAN 9/29/17 Analysis and Commentary STEVEN GROSSMAN 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More Analysis and Commentary STEVEN GROSSMAN 7/28/17 Analysis and Commentary STEVEN GROSSMAN 7/28/17 Challenges and Threats to FDA Resources: An Update Read More Advocacy at a Glance STEVEN GROSSMAN 7/8/16 Advocacy at a Glance STEVEN GROSSMAN 7/8/16 One Week until Congress’ Summer Adjournment Read More Analysis and Commentary STEVEN GROSSMAN 10/30/15 Analysis and Commentary STEVEN GROSSMAN 10/30/15 So ... How Do We Help FDA Get a Fair Cut of the Extra $40 Billion? Read More Advocacy at a Glance STEVEN GROSSMAN 10/9/15 Advocacy at a Glance STEVEN GROSSMAN 10/9/15 Will FSMA Make a Difference and more Read More Advocacy at a Glance STEVEN GROSSMAN 10/2/15 Advocacy at a Glance STEVEN GROSSMAN 10/2/15 DA Science Board Report Calls for Funding to Meet Responsibilities and more Read More Analysis and Commentary STEVEN GROSSMAN 5/1/15 Analysis and Commentary STEVEN GROSSMAN 5/1/15 FDA Funding and 21st Century Cures Read More Analysis and Commentary STEVEN GROSSMAN 2/6/15 Analysis and Commentary STEVEN GROSSMAN 2/6/15 POTUS's FY 16 Budget Request ... On Careful Reflection Read More
Analysis and Commentary STEVEN GROSSMAN 4/3/21 Analysis and Commentary STEVEN GROSSMAN 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More
Analysis and Commentary STEVEN GROSSMAN 1/10/20 Analysis and Commentary STEVEN GROSSMAN 1/10/20 FDA Is Its People Read More
STEVEN GROSSMAN 11/21/19 STEVEN GROSSMAN 11/21/19 Senate HELP Committee Interviews Stephen Hahn, MD Read More
Analysis and Commentary STEVEN GROSSMAN 9/29/17 Analysis and Commentary STEVEN GROSSMAN 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More
Analysis and Commentary STEVEN GROSSMAN 7/28/17 Analysis and Commentary STEVEN GROSSMAN 7/28/17 Challenges and Threats to FDA Resources: An Update Read More
Advocacy at a Glance STEVEN GROSSMAN 7/8/16 Advocacy at a Glance STEVEN GROSSMAN 7/8/16 One Week until Congress’ Summer Adjournment Read More
Analysis and Commentary STEVEN GROSSMAN 10/30/15 Analysis and Commentary STEVEN GROSSMAN 10/30/15 So ... How Do We Help FDA Get a Fair Cut of the Extra $40 Billion? Read More
Advocacy at a Glance STEVEN GROSSMAN 10/9/15 Advocacy at a Glance STEVEN GROSSMAN 10/9/15 Will FSMA Make a Difference and more Read More
Advocacy at a Glance STEVEN GROSSMAN 10/2/15 Advocacy at a Glance STEVEN GROSSMAN 10/2/15 DA Science Board Report Calls for Funding to Meet Responsibilities and more Read More
Analysis and Commentary STEVEN GROSSMAN 5/1/15 Analysis and Commentary STEVEN GROSSMAN 5/1/15 FDA Funding and 21st Century Cures Read More
Analysis and Commentary STEVEN GROSSMAN 2/6/15 Analysis and Commentary STEVEN GROSSMAN 2/6/15 POTUS's FY 16 Budget Request ... On Careful Reflection Read More
